all report title image

ORTHOKERATOLOGY MARKET ANALYSIS

Orthokeratology Market, By Product Type (Day-time Ortho-K Lenses and Overnight Ortho-K Lenses), By Material (Fluorosilicone Acrylate, Silicone Acrylate, Balafilcon, Oprifocon A), By Application (Myopia, Hyperopia, Presbyopia, Astigmatism), By End Users (Hospitals, Optometry Clinics, Ophthalmology Clinics, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Aug 2024
  • Code : CMI2193
  • Pages :154
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Orthokeratology Market Size and Trends

Global orthokeratology market is estimated to be valued at USD 420.4 Mn in 2024 and is expected to reach USD 595.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.1% from 2024 to 2031.

Orthokeratology Market Key Factors

Discover market dynamics shaping the industry: Request sample copy

The market growth is driven by increasing prevalence of myopia worldwide and growing preference for orthokeratology among both patients and eye care professionals as a non-invasive method to correct vision.

Global orthokeratology market growth is driven by increasing awareness about the benefits of orthokeratology such as reversibility and the temporary nature of the procedure. Ongoing technological advancements in orthokeratology lenses aimed at enhancing comfort and extended wear time can also drive the market growth.

Improving visual correction capabilities

Wearing orthokeratology lenses overnight improves one's eyesight by temporarily flattening the cornea. This non-invasive method allows corrective vision without dependence on glasses or contact lenses during waking hours. With continuous technological advancements, orthokeratology has proven to be a highly effective option for moderate to high degrees of myopia. Newer lens designs have significantly enhanced the refractive error range that can be treated. Lenses are customized with Precision UV technology to precisely reshape the corneal curvature according to one's prescription needs. This ensures optimal visual outcomes are achieved with minimal variability. The accuracy and effectiveness of orthokeratology correction has vastly improved in recent years. State-of-the-art lens characterization methods allow corneal mapping at an ultra-high resolution. Combined with sophisticated lens profiling techniques, this enables customized lens designs tailored for each individual patient's eye parameters. Clinically proven results show orthokeratology can reliably treat myopia levels up to -6.00 diopters and astigmatism up to -1.50 diopters with great predictability. Some innovative lens designs even expand the treatment spectrum to low hyperopia. The refinement in technological capabilities has provided orthokeratology wider acceptability as a reliable alternative to refractive surgery for moderate to high ametropia.

Market Concentration and Competitive Landscape

Orthokeratology Market Concentration By Players

Get actionable strategies to beat competition: Request sample copy

Growing acceptance among young demographic

Growing popularity of orthokeratology among the Young people can drive the market growth. Teenagers and young adults form a major end user segment for vision correction products. For this digitally active generation constantly engaged with screens, dependence on glasses can be quite problematic. Contact lenses provide an alternative but require daily maintenance and handling. Orthokeratology lenses have gained popularity within this group due to their convenience of overnight wear with clear vision during the day. Orthokeratology avoids risks of visual side effects that may arise from extended contact lens usage at a young age. Orthokeratology improves self-esteem and quality of life for teenagers with moderate to high myopia. The confidence boost from not having to wear glasses plays an important psychological role during formative years. Many orthokeratology adopters use it mainly for the convenience aspect, until these stabilize refractive error progression and consider more permanent vision correction options later in life. Favorable opinions shared on social media platforms have further boosted the acceptance of orthokeratology among young consumers globally. Lens manufacturers recognize this important demographic pillar and tailor appropriate marketing strategies accordingly.

Key Takeaways from Analyst:

Global orthokeratology market growth is driven by rising prevalence of myopia worldwide. Countries in Asia Pacific have witnessed rising cases of near-sightedness, an dthis can drive the market growth.  Growing awareness about orthokeratology treatment and its advantages over conventional methods for temporary control of myopia progression can also boost adoption. Orthokeratology lenses are considered safer and more comfortable options as compared to spectacles and contact lenses. Advancements in material science have improved the biocompatibility of lenses, thus, boosting its sales.

Lack of medical reimbursement coverage for orthokeratology treatment can hamper the market growth. High procedural costs can pose challenge for wider consumer acceptance in price-sensitive developing regions. Furthermore, prolonged overnight wear of lenses poses risks of infection and discomfort. Ongoing clinical trials evaluating the efficacy and safety of newer lens designs and materials can boost orthokeratology adoption over the forecast period. Favorable government policies promoting non-invasive options for myopia control can offer opportunities for market players.

Market Challenges: Risk of corneal infections associated with orthokeratology lens usage

The risk of corneal infections associated with orthokeratology lens usage can hamper the growth of global orthokeratology market. Orthokeratology lenses are worn overnight to temporarily reshape the cornea and reduce near-sightedness during the day without glasses. However, prolonged overnight usage increases the risk of developing corneal infections. Several medical studies have found a higher occurrence of microbial keratitis, a serious corneal infection, in orthokeratology lens users as compared to normal soft contact lenses. For example, as per a  retrospective study from 2008-2014, across eight eye clinics in Hong Kong, orthokeratology lens usage accounted for about 44% of all contact lens related microbial keratitis cases, despite orthokeratology lenses constituting a small portion of the contact lens market. In  2021, according to a study analyzing 623 cases of contact lens related keratitis in the U.S. from 2015-2019, orthokeratology lens use was associated with the highest risk and worst visual outcomes compared to other types of contact lenses. Parents and individuals are wary of the infection risks, thus, decreasing its demand. Several government regulatory bodies like the U.S. FDA have issued warnings about orthokeratology lens usage, emphasizing the need for proper fitting and handling to reduce risks. Doctors are also reluctant to widely prescribe orthokeratology lenses until safety improves.

Market Opportunities: Developing regions present high growth potential

Developing regions present significant growth potential for the global orthokeratology market due to their rapid economic development, increasing disposable incomes, and improved access to healthcare services. Rising living standards increases awareness about vision correction options, thus, boosting popularity of orthokeratology. High-potential areas include Asia Pacific, Latin America, the Middle East, and Africa. Asia Pacific, with its high myopia rates, and Africa, projected to see a population surge, both offer large untapped markets. Supportive government initiatives, like India's 'Vision Fast Track Initiative,' can also offer growth opportunities. With targeted marketing and affordable products, orthokeratology companies can capture substantial market share in these developing regions.

Orthokeratology Market By Product Type

Discover high revenue pocket segments and roadmap to it: Request sample copy

By Product Type- Convenience and Effectiveness Boosts Demand for Overnight Ortho-K Lenses

In terms of product type, overnight ortho-K lenses segment is estimated to contribute the highest market share of 59.1% in 2024, owing to their convenience and effectiveness. Overnight lenses offer patients the flexibility to simply wear their lenses overnight and remove them in the morning. This allows patients to avoid the hassle of wearing lenses during waking hours, and giving their eyes extended periods of rest. The overnight wear schedule is as effective as daytime wear in correcting low to moderate levels of nearsightedness. Orthokeratology works through controlled reshaping of the cornea while eyes are closed and at rest during sleep. Overnight lenses efficiently modulate corneal reshaping through continuous gentle force applied overnight. This completeness of treatment has made overnight lenses a preferred choice.

By Material- Superior Material Properties Boosts Uptake of Fluorosilicone Acrylate Lenses

In terms of material, fluorosilicone acrylate segment is estimated to contribute the highest market share of 40.21% in 2024, due to its advanced material properties. Fluorosilicone acrylate lenses are highly breathable and flexible. This allows them to move smoothly with blinking and reduce irritation. The material is designed to maximally oxygenate the cornea even during long periods of wear. This provides patients increased comfort levels. The enhanced elastic properties of fluorosilicone acrylate allows it to gently reshape the cornea with minimal force, reducing risk of complications. The biocompatibility of this material has also been shown to support corneal health. These superior properties have increased patient satisfaction with fluorosilicone acrylate lenses.

By Application- High Prevalence and Early Onset Boosts Demand for Myopia Treatment

In terms of application, myopia segment is estimated to contribute the highest market share of 52% in 2024, due to high and growing prevalence of myopia globally. Myopia is one of the most common vision conditions affecting people of all ages. In particular, its early onset and continued rise in pediatric populations have elevated demand for myopia control treatments such as orthokeratology. The prevalence of myopia in children has doubled over the past few decades. With growing use of digital devices and reduced outdoor time implicated as risks for faster myopia progression in young years, early intervention has become a priority. Orthokeratology enables non-invasive treatment of low to moderate myopia through overnight wear of corrective lenses and slowing further increases in nearsightedness.

Regional Insights

Orthokeratology Market Regional Insights

To learn more about this report, Request sample copy

North America dominates the global orthokeratology market with an estimated market share of 41.3% in 2024. The region boasts strong presence of leading industry players with established manufacturing and R&D facilities. Major players such as Johnson & Johnson Vision and Bausch & Lomb have their headquarters located in the U.S., allowing them to cater to local demand efficiently. Favorable reimbursement policies for medical devices and eye care products contribute to higher product adoption. Patients in the U.S. and Canada are quick to adopt the latest technologies and orthokeratology is gaining popularity as a non-invasive option for vision correction.

Asia Pacific has emerged as the fastest growing regional market for orthokeratology. China, in particular, plays a key role in driving the market growth in the region. The staggering population, rising disposable income, and growing focus on ophthalmic treatments boosts demand from countries such as China and India. The availability of cheaper alternatives compared to refractive surgeries prmpt many individuals to opt for the orthokeratology treatment method. Local manufacturers are strengthening their position by offering products at competitive prices. This has boosted the affordability of orthokeratology devices and accelerated the penetration of branded products as well. Furthermore, increasing medical tourism and high incidence of myopia among students in countries like China and South Korea are boosting adoption. Countries in Southeast Asia are also expected to contribute significantly to the market expansion in Asia Pacific.

Market Report Scope

Orthokeratology Market Report Coverage

Report Coverage Details
Base Year: 2023 Market Size in 2024: US$ 420.4 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 5.1% 2031 Value Projection: US$ 595.1 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: South Africa, North Africa, Central Africa
Segments covered:
  • By Product Type: Day-time Ortho-K Lenses and Overnight Ortho-K Lenses
  • By Material: Fluorosilicone Acrylate, Silicone Acrylate, Balafilcon, Oprifocon A
  • By Application: Myopia, Hyperopia, Presbyopia, Astigmatism
  • By End Users: Hospitals, Optometry Clinics, Ophthalmology Clinics, Others 
Companies covered:

Bausch + Lomb, Johnson & Johnson Vision, CooperVision, GP Specialists, Paragon Vision Sciences, Alpha Corporation, Euclid Systems Corporation, Procornea, Art Optical Contact Lens, Inc., Brighten Optix, Menicon, E&E Optics, Autek China, Precilens, AOK Group, Gelflex, Essilor International S.A., TFOS Orthokeratology

Growth Drivers:
  • Improving Visual Correction Capabilities
  • Growing Acceptance Among Young Demographic
Restraints & Challenges:
  • Risk of corneal infections associated with orthokeratology lens usage
  • Stringent regulatory environment for new lens approvals

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Orthokeratology Industry News

  • In May 2023, Menicon Co. Ltd. introduced its “Menicon Z Night” orthokeratology lenses in China. These lenses are already popular in Southeast Asia, Australia, and Europe.
  • In January 2023, CooperVision Specialty EyeCare launched  Visavy, a pioneering digital fitting tool, at the 2023 Global Specialty Lens Symposium (GSLS). Pronounced Vee-SAH-vee, this tool utilizes topography-guided algorithms to assist in the design and selection of Paragon CRT orthokeratology contact lenses through a user-friendly web-based fitting program, enhancing myopia control.
  • In October 2022, Johnson & Johnson Vision, a leader in eye health and part of Johnson & Johnson MedTech, received Health Canada approval for ACUVUE Abiliti Overnight Therapeutic Lenses for myopia management. These ortho-k lenses are designed to reshape the cornea overnight for myopia control. This approval follows the September 2021 approval of ACUVUE Abiliti 1-Day Soft Therapeutic Lenses.
  • In September 2021, Scotlens partnered with Avizor to launch ‘Nocturnal by Scotlens,’ a premium unboxing experience for ortho-K night lenses, aiming to boost public awareness and excitement about this eye care innovation. While ortho-K lenses have significant potential, their marketing has lagged behind that of laser surgery and fashionable eyewear.

*Definition: Global Orthokeratology Market involves the design, development, and manufacturing of contact lenses used for overnight orthokeratology, a non-surgical alternative to correct refractive errors like myopia and hyperopia. The orthokeratology contact lenses are specially designed to gently reshape the cornea while worn overnight to temporarily improve vision without glasses or contact lenses during waking hours. Global leaders in this market supply orthokeratology lenses and related products globally to optometrists and consumers looking for non-invasive vision correction solutions.

Market Segmentation

  •  Product Type Insights (Revenue, USD Mn, 2019 - 2031)
    • Day-time Ortho-K Lenses
    • Overnight Ortho-K Lenses
  •  Material Insights (Revenue, USD Mn, 2019 - 2031)
    • Fluorosilicone Acrylate
    • Silicone Acrylate
    • Balafilcon
    • Oprifocon A
  •  Application Insights (Revenue, USD Mn, 2019 - 2031)
    • Myopia
    • Hyperopia
    • Presbyopia
    • Astigmatism
  •  End Users Insights (Revenue, USD Mn, 2019 - 2031)
    • Hospitals
    • Optometry Clinics
    • Ophthalmology Clinics
    • Others
  • Regional Insights (Revenue, USD Mn, 2019 - 2031)
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa
  • Key Players Insights
    • Bausch + Lomb
    • Johnson & Johnson Vision
    • CooperVision
    • GP Specialists
    • Paragon Vision Sciences
    • Alpha Corporation
    • Euclid Systems Corporation
    • Procornea
    • Art Optical Contact Lens, Inc.
    • Brighten Optix
    • Menicon
    • E&E Optics
    • Autek China
    • Precilens
    • AOK Group
    • Gelflex
    • Essilor International S.A.
    • TFOS Orthokeratology

Share

About Author

Ghanshyam Shrivastava - With over 20 years of experience in the management consulting and research, Ghanshyam Shrivastava serves as a Principal Consultant, bringing extensive expertise in biologics and biosimilars. His primary expertise lies in areas such as market entry and expansion strategy, competitive intelligence, and strategic transformation across diversified portfolio of various drugs used for different therapeutic category and APIs. He excels at identifying key challenges faced by clients and providing robust solutions to enhance their strategic decision-making capabilities. His comprehensive understanding of the market ensures valuable contributions to research reports and business decisions.

Ghanshyam is a sought-after speaker at industry conferences and contributes to various publications on pharma industry.

Missing comfort of reading report in your local language? Find your preferred language :

Frequently Asked Questions

The global Orthokeratology Market size is estimated to be valued at USD 420.4 million in 2024 and is expected to reach USD 595.1 million in 2031.

The CAGR of global orthokeratology market is projected to be 5.1% from 2024 to 2031.

Improving visual correction capabilities and growing acceptance among young demographic are the major factors driving the growth of global orthokeratology market.

Risk of corneal infections associated with orthokeratology lens usage and stringent regulatory environment for new lens approvals are the major factors hampering the growth of global orthokeratology market.

In terms of product type, overnight ortho-K lenses segment is estimated to dominate the market in 2024.

Bausch + Lomb, Johnson & Johnson Vision, CooperVision, GP Specialists, Paragon Vision Sciences, Alpha Corporation, Euclid Systems Corporation, Procornea, Art Optical Contact Lens, Inc., Brighten Optix, Menicon, E&E Optics, Autek China, Precilens, AOK Group, Gelflex, Essilor International S.A., TFOS Orthokeratology are the major players.

North America is expected to lead the global orthokeratology market.
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

Select a License Type





Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.